vip152
Showing 1 - 2 of 2
Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement
Recruiting
- Lymphoma
- +4 more
- Vysis LSI MYC Break Apart Rearrangement Probe Kit
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United
Recruiting
- Relapsed Non Hodgkin Lymphoma
- +6 more
- VIP152
-
Cincinnati, Ohio
- +4 more
Aug 3, 2022